Jonathan Sears, MD, is Associate Professor of Ophthalmology at the Cole Eye Institute, Cleveland Clinic. He received his undergraduate education at Yale College, graduating cum laude with a BS in chemistry. He continued with medical school at Yale University School of Medicine, where he developed a novel method of screening B-cell epitopes, which was used to help develop the Lyme vaccine. He was a Resident in Ophthalmology at Yale as well, and next completed a two-year surgical fellowship at Emory University, where he developed an interest in pediatric retinal detachment and retinopathy of prematurity (ROP).

Dr. Sears' research interest is in ROP. He uses a mouse model of ROP to test the hypothesis that small-molecule activators of hypoxia-inducible factor are able to drive retinal development early in life to prevent ROP detachment.

Fellowship - Emory University Hospital

Vitreoretinal Fellowship
Decatur, GA USA
1998

Residency - Yale-New Haven Hospital

Ophthalmology
New Haven, CT USA
1996

Internship - Yale-New Haven Hospital

Internal Medicine
New Haven, CT USA
1993

Medical School - Yale University School of Medicine

New Haven, CT
1992

Undergraduate - Yale University

Chemistry
New Haven, CT USA
1988

• Ophthalmology

• Distinction in Chemistry, Department of Chemistry, Yale University, 1988
• Cum Laude, Yale University, 1988
• Yale Medical Student Research Fellowship, sponsored by National Institutes of Health; Howard Hughes Medical Institute, Section of Immunobiology, Yale School of Medicine, 1990-1992
• Harold J. Lamport Prize, awarded for the most creative biomedical research by a Yale medical student, Department of Biochemistry, Yale School of Medicine, 1992
• Yale Resident Research Prize, Department of Ophthalmology, 1995 and 1996
• Heed Ophthalmic Fellowship, in support of clinical research, 1997
• Emory Medical Care Fellowship, in support of basic science research, Emory University School of Medicine, 1997
• Association of University Professors of Ophthalmology, Fellow Research Competition, Finalist, 1998
• Clinical Teacher of the Year Award, Department of Ophthalmology, Emory University School of Medicine, 1998
• Clinical Investigator Development Award, Cleveland Clinic, 2003
• Best Doctors in America, 2005-2009
• Best Doctors in Cleveland, 2005-2009
• American Academy of Ophthalmology Achievement Award, 2007
• Editorial Board Member Online News and Education (O.N.E.), 2007
• Editorial Board Member British Journal of Ophthalmology
• Best Research, Poster American Academy of Ophthalmology, 2008
• Strathmore Who's Who 2009

• American Academy of Ophthalmology
• Association of Research in Vision and Ophthalmology
• International Congress of Eye Research
• Cleveland Ophthalmic Society
• Heed Ophthalmic Society

• Laser For Diabetic Retinopathy
• Laser Indirect Ophthalmoscopy For ROP
• Lens-sparing Vitrectomy
• Ophthalmology
• Pars Plana Vitrectomy
• Scleral Buckle

• Acquired Vitreoretinal Diseases
• Diabetic Retinopathy
• Lens Dislocation
• Pediatric Retinal Detachment
• Retinal Detachment
• Retinal Disorders
• Retinopathy Of Prematurity
• Traumatic Retinal Detachment

Cleveland Clinic physicians and scientists report if they have any collaborations with the pharmaceutical or medical device industries as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 7/31/2008, Dr. Sears has reported no financial relationship with industry that is applicable to this listing. Patients should feel free to contact their doctor about relationships with industry and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

• English